IMAGE PROBLEM –
Big Pharma’s public image sinks to new low amid opioid crisis, high drug prices
| Sep 4, 2019
| Ars Technica – The pharmaceutical industry is now the most widely hated industry in the US, according to a new Gallup poll.
The pharmaceutical industry’s bottom rank marks its lowest rating in the history of the poll, which began in 2001.
Gallup noted that the polling came amid widespread backlash from high drug prices, the opioid epidemic, and pharmaceutical companies’ massive lobbying efforts to undermine popular policy initiatives.
In fact, on Tuesday, STAT news reported that top pharma executives are using their own personal wealth to fund a small band of Senators who have sway over legislation that would affect the drug industry.
A pending Senate bill to lower drug costs would cut industry revenue by some $85 billion over the next decade if passed.
Executives from Eli Lilly, Pfizer, Sanofi, and Amgen have personally given roughly $200,000 in campaign donations in the past year to select senators including Majority Leader Mitch McConnell (R-Ky.), Sen. John Cornyn (R-Texas), and Sen. Thom Tillis (R-N.C.). Read more.
MORE OF TODAY’S TOP HEALTH NEWS: